ACPU
MDCO

Arrowgrass Capital Partners (US)’s Medicines Co MDCO Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-85,000
Closed -$2.38M – 585
2015
Q1 		$2.38M Buy
+85,000
New +$2.39M 0.04% 238

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s MDCO Position: Q2 2015 in Review

Arrowgrass Capital Partners (US) sold out of Medicines Co (MDCO) in Q2 2015, closing a stake of 85,000 shares — an estimated $2.38M sold.

Arrowgrass Capital Partners (US) first reported a position in MDCO in Q1 2015 and held it in 1 quarter. The position peaked at $2.38M in Q1 2015. 172 funds tracked by Wall St. Rank hold MDCO as of Q2 2015.

  • Arrowgrass Capital Partners (US) reported no remaining Medicines Co position as of Q2 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 85,000 Medicines Co shares in Q2 2015, an estimated $2.38M.
  • Arrowgrass Capital Partners (US) first reported a position in Medicines Co in Q1 2015 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s Medicines Co position peaked at $2.38M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q2 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2015, filed 14 Aug 2015.